Find Clinical Trial

An open-label, randomised, phase III study comparing trifluridine/tipiracil in combination with bevacizumab to trifluridine/tipiracil monotherapy in patients with refractory metastatic colorectal cancer

← Back
Study Phase

Phase 3

Therapeutic Area


IndicationRefractory metastatic colorectal cancer, Solid tumors
SponsorInstitut de Recherches Internationales Servier (I.R.I.S.)
Active substance/
Medical device


Active Substance CodeS095005
Protocol CodeCL3-95005-007
EudraCT Code2020-001976-14
NCT CodeNCT04737187

Documents and links

First lay summary
Second lay summary
First results summary READ MORE
Second results summary READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.